001package org.hl7.fhir.r4.model.codesystems; 002 003/* 004 Copyright (c) 2011+, HL7, Inc. 005 All rights reserved. 006 007 Redistribution and use in source and binary forms, with or without modification, 008 are permitted provided that the following conditions are met: 009 010 * Redistributions of source code must retain the above copyright notice, this 011 list of conditions and the following disclaimer. 012 * Redistributions in binary form must reproduce the above copyright notice, 013 this list of conditions and the following disclaimer in the documentation 014 and/or other materials provided with the distribution. 015 * Neither the name of HL7 nor the names of its contributors may be used to 016 endorse or promote products derived from this software without specific 017 prior written permission. 018 019 THIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND CONTRIBUTORS "AS IS" AND 020 ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED 021 WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE ARE DISCLAIMED. 022 IN NO EVENT SHALL THE COPYRIGHT HOLDER OR CONTRIBUTORS BE LIABLE FOR ANY DIRECT, 023 INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES (INCLUDING, BUT 024 NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES; LOSS OF USE, DATA, OR 025 PROFITS; OR BUSINESS INTERRUPTION) HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, 026 WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) 027 ARISING IN ANY WAY OUT OF THE USE OF THIS SOFTWARE, EVEN IF ADVISED OF THE 028 POSSIBILITY OF SUCH DAMAGE. 029 030*/ 031 032// Generated on Wed, Jan 30, 2019 16:19-0500 for FHIR v4.0.0 033 034import org.hl7.fhir.exceptions.FHIRException; 035 036public enum ResearchStudyPhase { 037 038 /** 039 * Trials without phases (for example, studies of devices or behavioral 040 * interventions). 041 */ 042 NA, 043 /** 044 * Designation for optional exploratory trials conducted in accordance with the 045 * United States Food and Drug Administration's (FDA) 2006 Guidance on 046 * Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0. 047 */ 048 EARLYPHASE1, 049 /** 050 * Includes initial studies to determine the metabolism and pharmacologic 051 * actions of drugs in humans, the side effects associated with increasing 052 * doses, and to gain early evidence of effectiveness; may include healthy 053 * participants and/or patients. 054 */ 055 PHASE1, 056 /** 057 * Trials that are a combination of phases 1 and 2. 058 */ 059 PHASE1PHASE2, 060 /** 061 * Includes controlled clinical studies conducted to evaluate the effectiveness 062 * of the drug for a particular indication or indications in participants with 063 * the disease or condition under study and to determine the common short-term 064 * side effects and risks. 065 */ 066 PHASE2, 067 /** 068 * Trials that are a combination of phases 2 and 3. 069 */ 070 PHASE2PHASE3, 071 /** 072 * Includes trials conducted after preliminary evidence suggesting effectiveness 073 * of the drug has been obtained, and are intended to gather additional 074 * information to evaluate the overall benefit-risk relationship of the drug. 075 */ 076 PHASE3, 077 /** 078 * Studies of FDA-approved drugs to delineate additional information including 079 * the drug's risks, benefits, and optimal use. 080 */ 081 PHASE4, 082 /** 083 * added to help the parsers 084 */ 085 NULL; 086 087 public static ResearchStudyPhase fromCode(String codeString) throws FHIRException { 088 if (codeString == null || "".equals(codeString)) 089 return null; 090 if ("n-a".equals(codeString)) 091 return NA; 092 if ("early-phase-1".equals(codeString)) 093 return EARLYPHASE1; 094 if ("phase-1".equals(codeString)) 095 return PHASE1; 096 if ("phase-1-phase-2".equals(codeString)) 097 return PHASE1PHASE2; 098 if ("phase-2".equals(codeString)) 099 return PHASE2; 100 if ("phase-2-phase-3".equals(codeString)) 101 return PHASE2PHASE3; 102 if ("phase-3".equals(codeString)) 103 return PHASE3; 104 if ("phase-4".equals(codeString)) 105 return PHASE4; 106 throw new FHIRException("Unknown ResearchStudyPhase code '" + codeString + "'"); 107 } 108 109 public String toCode() { 110 switch (this) { 111 case NA: 112 return "n-a"; 113 case EARLYPHASE1: 114 return "early-phase-1"; 115 case PHASE1: 116 return "phase-1"; 117 case PHASE1PHASE2: 118 return "phase-1-phase-2"; 119 case PHASE2: 120 return "phase-2"; 121 case PHASE2PHASE3: 122 return "phase-2-phase-3"; 123 case PHASE3: 124 return "phase-3"; 125 case PHASE4: 126 return "phase-4"; 127 case NULL: 128 return null; 129 default: 130 return "?"; 131 } 132 } 133 134 public String getSystem() { 135 return "http://terminology.hl7.org/CodeSystem/research-study-phase"; 136 } 137 138 public String getDefinition() { 139 switch (this) { 140 case NA: 141 return "Trials without phases (for example, studies of devices or behavioral interventions)."; 142 case EARLYPHASE1: 143 return "Designation for optional exploratory trials conducted in accordance with the United States Food and Drug Administration's (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0."; 144 case PHASE1: 145 return "Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients."; 146 case PHASE1PHASE2: 147 return "Trials that are a combination of phases 1 and 2."; 148 case PHASE2: 149 return "Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks."; 150 case PHASE2PHASE3: 151 return "Trials that are a combination of phases 2 and 3."; 152 case PHASE3: 153 return "Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug."; 154 case PHASE4: 155 return "Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use."; 156 case NULL: 157 return null; 158 default: 159 return "?"; 160 } 161 } 162 163 public String getDisplay() { 164 switch (this) { 165 case NA: 166 return "N/A"; 167 case EARLYPHASE1: 168 return "Early Phase 1"; 169 case PHASE1: 170 return "Phase 1"; 171 case PHASE1PHASE2: 172 return "Phase 1/Phase 2"; 173 case PHASE2: 174 return "Phase 2"; 175 case PHASE2PHASE3: 176 return "Phase 2/Phase 3"; 177 case PHASE3: 178 return "Phase 3"; 179 case PHASE4: 180 return "Phase 4"; 181 case NULL: 182 return null; 183 default: 184 return "?"; 185 } 186 } 187 188}